These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28645291)

  • 21. Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis.
    Jarrett SJ; Conaghan PG; Sloan VS; Papanastasiou P; Ortmann CE; O'Connor PJ; Grainger AJ; Emery P
    Arthritis Rheum; 2006 May; 54(5):1410-4. PubMed ID: 16645968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of combined androgen blockade with zoledronic acid treatment in prostate cancer with bone metastasis: the ZABTON-PC (zoledronic acid/androgen blockade trial on prostate cancer) study.
    Ueno S; Mizokami A; Fukagai T; Fujimoto N; Oh-Oka H; Kondo Y; Arai G; Ide H; Horie S; Ueki O; Kawaguchi K; Shimamura M; Orito M; Ishida T; Ikeda D; Namiki M
    Anticancer Res; 2013 Sep; 33(9):3837-44. PubMed ID: 24023317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of long-term alendronic acid treatment on Modic changes in the lumbar spine: a gender and age-matched study.
    Yiu K; Ahn H; Shea GK
    J Orthop Surg Res; 2024 May; 19(1):291. PubMed ID: 38735917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hybrid Bone Single Photon Emission Computed Tomography Imaging in Evaluation of Chronic Low Back Pain: Correlation with Modic Changes and Degenerative Disc Disease.
    Russo VM; Dhawan RT; Dharmarajah N; Baudracco I; Lazzarino AI; Casey AT
    World Neurosurg; 2017 Aug; 104():816-823. PubMed ID: 28377243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of Zoledronic Acid on Atrial Electrophysiological Parameters and Electrocardiographic Measurements.
    Tisdale JE; Allen MR; Overholser BR; Jaynes HA; Kovacs RJ
    J Cardiovasc Electrophysiol; 2015 Jun; 26(6):671-7. PubMed ID: 25684326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No effect of 6-month intake of glucosamine sulfate on Modic changes or high intensity zones in the lumbar spine: sub-group analysis of a randomized controlled trial.
    Wilkens P; Storheim K; Scheel I; Berg L; Espeland A
    J Negat Results Biomed; 2012 Aug; 11():13. PubMed ID: 22900984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats.
    Little DG; Peat RA; Mcevoy A; Williams PR; Smith EJ; Baldock PA
    J Bone Miner Res; 2003 Nov; 18(11):2016-22. PubMed ID: 14606515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PTH(1-34) and zoledronic acid have differing longitudinal effects on juvenile mouse femur strength and morphology.
    Bartlow CM; Oest ME; Mann KA; Zimmerman ND; Butt BB; Damron TA
    J Orthop Res; 2017 Aug; 35(8):1707-1715. PubMed ID: 27653318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of zoledronic acid to prevent further bone loss in osteoporotic patients undergoing androgen deprivation therapy for prostate cancer.
    Wadhwa VK; Weston R; Parr NJ
    BJU Int; 2010 Apr; 105(8):1082-8. PubMed ID: 19912210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zoledronic acid in children with osteogenesis imperfecta and Bruck syndrome: a 2-year prospective observational study.
    Otaify GA; Aglan MS; Ibrahim MM; Elnashar M; El Banna RA; Temtamy SA
    Osteoporos Int; 2016 Jan; 27(1):81-92. PubMed ID: 26138583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid.
    Cleeland CS; Body JJ; Stopeck A; von Moos R; Fallowfield L; Mathias SD; Patrick DL; Clemons M; Tonkin K; Masuda N; Lipton A; de Boer R; Salvagni S; Oliveira CT; Qian Y; Jiang Q; Dansey R; Braun A; Chung K
    Cancer; 2013 Feb; 119(4):832-8. PubMed ID: 22951813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amoxicillin Did Not Reduce Modic Change Edema in Patients With Chronic Low Back Pain: Subgroup Analyses of a Randomised Trial (the AIM Study).
    Kristoffersen PM; Vetti N; Grøvle L; Brox JI; Haugli Bråten LC; Grotle M; Julsrud Haugen A; Rolfsen MP; Froholdt A; Skouen JS; Lutro O; Marchand GH; Anke A; Zwart JA; Storheim K; Assmus J; Espeland A
    Spine (Phila Pa 1976); 2023 Feb; 48(3):147-154. PubMed ID: 36223435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zoledronic acid effectively prevents aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-FAST study 36-month follow-up results.
    Brufsky AM; Bosserman LD; Caradonna RR; Haley BB; Jones CM; Moore HC; Jin L; Warsi GM; Ericson SG; Perez EA
    Clin Breast Cancer; 2009 May; 9(2):77-85. PubMed ID: 19433387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantation.
    D'Souza AB; Grigg AP; Szer J; Ebeling PR
    Intern Med J; 2006 Sep; 36(9):600-3. PubMed ID: 16911552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
    Cosman F; Eriksen EF; Recknor C; Miller PD; Guañabens N; Kasperk C; Papanastasiou P; Readie A; Rao H; Gasser JA; Bucci-Rechtweg C; Boonen S
    J Bone Miner Res; 2011 Mar; 26(3):503-11. PubMed ID: 20814967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.
    Gnant M; Mlineritsch B; Luschin-Ebengreuth G; Kainberger F; Kässmann H; Piswanger-Sölkner JC; Seifert M; Ploner F; Menzel C; Dubsky P; Fitzal F; Bjelic-Radisic V; Steger G; Greil R; Marth C; Kubista E; Samonigg H; Wohlmuth P; Mittlböck M; Jakesz R;
    Lancet Oncol; 2008 Sep; 9(9):840-9. PubMed ID: 18718815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploratory study for clinical signs of MODIC changes in patients with low-back pain in the Netherlands armed forces.
    van der Wurff P; Vredeveld T; van de Graaf C; Jensen RK; Jensen TS
    Chiropr Man Therap; 2019; 27():5. PubMed ID: 30809377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimental Staphylococcus aureus-induced arthritis.
    Verdrengh M; Carlsten H; Ohlsson C; Tarkowski A
    J Orthop Res; 2007 Mar; 25(3):304-10. PubMed ID: 17089391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-utility analysis of antibiotic treatment in patients with chronic low back pain and Modic changes: results from a randomised, placebo-controlled trial in Norway (the AIM study).
    Grotle M; Bråten LC; Brox JI; Espeland A; Zolic-Karlsson Z; Munk Killingmo R; Tingulstad A; Grøvle L; Froholdt A; Kristoffersen PM; Wigemyr M; van Tulder MW; Storheim K; Zwart JA;
    BMJ Open; 2020 Jun; 10(6):e035461. PubMed ID: 32546490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zoledronic acid does not reduce MRI erosive progression in PsA but may suppress bone oedema: the Zoledronic Acid in Psoriatic Arthritis (ZAPA) Study.
    McQueen F; Lloyd R; Doyle A; Robinson E; Lobo M; Exeter M; Taylor WJ; Jones P; Reid IR; Dalbeth N
    Ann Rheum Dis; 2011 Jun; 70(6):1091-4. PubMed ID: 21342915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.